Burcu Yigit is Associate Director of Pharmacology focused on characterization and validation of Cartography’s modalities. Prior to joining Cartography, Burcu was a senior scientist at MiNK Therapeutics, developing iNKT cells as an allogeneic cell therapy platform. She completed her PhD in lab of Cox Terhorst at BIDMC/Harvard Medical School, focused on immune modulating effects of targeting SLAMF6 in chronic lymphocytic leukemia. In her spare time, she enjoys running, reading and spending time with her family, two cats and friends.